As of a September 25, 2025 data cut-off-date, 10 patients with treatment-refractory, moderate-to-severe Systemic Lupus Erythematosus (SLE) were treated with a single dose of FT819 with less-intensive ...
As of a September 25, 2025 data cut-off-date, 10 patients with treatment-refractory, moderate-to-severe Systemic Lupus Erythematosus (SLE) were ...
The same cell product could potentially be used to treat multiple solid tumors like ovarian, pancreatic and lung cancers.
So far, immune cells that have been engineered to kill cancers, known as CAR T-cells, haven’t worked well against solid ...
Abstract: We evaluated and designed the canted angle and magnetic properties of canted spin-orbit torque (SOT) MRAM cells fabricated in a 300mm CMOS fully compatible process. In the results, we ...
The plans, if implemented, would result in the layoff of about 365 employees. Galapagos said it will still entertain acquisition offers as it works to close the unit. Galapagos was once a high-flyer ...
Overall and event-free survival of 100 and 95%, respectively, seen with autologous CD34+ hematopoietic stem-cell lentiviral gene therapy.
Abstract: In this paper, we investigate the utilization of movable antennas (MAs) in cell-free networks to reduce transmit power consumption. Different from conventional networks with fixed-position ...
The SHARON trial is ongoing and will be expanding to include patients without a BRCA or PALB2 mutation, and General Oncology plans to continue evaluating outcomes and long-term follow-up in this ...
For children born with severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID), an investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback